Filter
1843
Filtered Results: 1843
Text search:
Avert
Featured
Recommendations
138
New Publications
433
Language
Document type
No document type
864
Studies & Reports
366
Guidelines
281
Manuals
117
Strategic & Response Plan
101
Fact sheets
36
Training Material
27
Situation Updates
20
Infographics
17
Brochures
10
Online Courses
3
Resource Platforms
1
Countries / Regions
Global
116
Brazil
72
Kenya
50
Mozambique
48
Ethiopia
43
India
42
Africa
41
Nigeria
34
Latin America and the Carribbean
32
Senegal
29
Myanmar / Burma
26
Angola
25
South Africa
22
Zambia
22
Bangladesh
20
Uganda
20
Sierra Leone
19
Burkina Faso
19
Asia
19
Congo, Democratic Republic of
19
Guinea
18
Nepal
17
South–East Asia Region
16
Western and Central Europe
16
Paraguay
16
Tanzania
15
Liberia
14
Philippines
13
Guinea-Bissau
13
Venezuela
13
Ukraine
12
Rwanda
12
Syria
12
Malawi
12
Argentina
12
Mali
12
Cameroon
11
Peru
10
Namibia
10
South Sudan
10
Ghana
9
Cambodia
9
Germany
9
Yemen
9
Colombia
8
Benin
8
Chile
8
Haiti
8
Côte d’Ivoire / Ivory Coast
8
Lesotho
7
East and Southern Africa
7
Ecuador
7
Pakistan
7
Zimbabwe
6
Bolivia
6
Indonesia
6
Afghanistan
5
West and Central Africa
5
Portugal
5
Eastern Europe
5
Chad
5
Somalia
5
Niger
4
Tajikistan
3
Thailand
3
Togo
3
China
3
Kyrgyzstan
3
Middle East and North Africa
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
France
3
Lebanon
3
Vietnam
3
Russia
3
Sudan
3
Central African Republic
3
Honduras
3
Madagascar
3
Mexico
2
El Salvador
2
Kazakhstan
2
Estonia
2
Armenia
2
Jamaica
2
Spain
2
Djibouti
2
Palestine
2
Botswana
2
Iraq
2
Eswatini/ Swaziland
2
Guatemala
2
North Macedonia
1
Serbia
1
Turkey
1
Gambia
1
Iran
1
Albania
1
Canada
1
Laos
1
Congo-Brazzaville
1
Burundi
1
Mauritania
1
Dominican Republic
1
Hungary
1
Luxembourg
1
Uruguay
1
Belgium
1
United Kingdom
1
Israel
1
Nicaragua
1
Moldova
1
Romania
1
Georgia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
685
Clinical Guidelines
128
Women & Child Health
112
Key Resources
92
Public Health
82
Pharmacy & Technologies
19
Capacity Building
14
Toolboxes
COVID-19
225
HIV
197
TB
111
Mental Health
88
Planetary Health
83
AMR
51
NTDs
50
Malaria
49
Conflict
43
Ebola & Marburg
39
Caregiver
39
Health Financing Toolbox
33
Disability
32
Global Health Education
32
NCDs
25
Rapid Response
24
Refugee
21
Natural Hazards
21
Pharmacy
18
2.0 Rapid Response
17
Social Ethics
16
Zika
16
Specific Hazards
14
Polio
11
Cholera
10
Typhoon
2
This document by Medicines for Malaria Venture (MMV) highlights the significant burden of malaria on children worldwide, emphasizing the need for effective prevention, diagnosis, and treatment strategies. It reviews current challenges and progress in combating pediatric malaria, advocating for conti...
Report of a virtual meeting 21–23 June 2022
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
Le pilier 3 de la Stratégie technique mondiale de lutte contre le paludisme 2016–2030 consiste à faire de la surveillance du paludisme une intervention de base dans tous les pays d’endémie palustre et dans ceux ayant éliminé le paludisme mais où la transmission pourrait reprendre. Ce nouve...
Preferred product characteristics and clinical development considerations
Depuis 2010, la lutte contre le paludisme a permis de réaliser des progrès majeurs grâce à la distribution de moustiquaires, au diagnostic rapide, aux traitements à base d'artémisinine (ACT) et aux interventions préventives ciblées.
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
This operational guidance provides a structured approach to support countries in sustaining priority services for HIV, viral hepatitis and sexually transmitted infections in the context of reduced external funding. The guidance is intended for national governments, public health programmes, communit...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
Noncommunicable diseases (NCDs) (e.g., cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases) and mental health conditions (e.g., Alzheimer’s disease and related dementias, depression, anxiety, autism spectrum disorders) are the world’s leading cause of preventable illness...
Règlement sanitaire international (2005)
recommended
La troisième édition du RSI intègre les amendements à l’annexe 7 qui ont été adoptés par la Soixante-Septième Assemblée mondiale de la Santé, par la résolution WHA67.13 (2014). Aux termes de l’annexe 7 modifiée, la durée de la protection conférée par l’administration d’un vacc...
Drawing on the World Health Organization’s package of NCD best buys, the report demonstrates how these evidence-based measures can help countries reduce premature deaths, strengthen health systems, and advance progress towards the Sustainable Development Goals. It provides policymakers, donors, ad...
WHO guideline on HIV service delivery
recommended
Updated guidance on the integration of diabetes, hypertension and mental health services, and interventions to support adherence to antiretroviral therapy. The guideline offers practical implementation guidance for countries and key stakeholders as well as outlining key research gaps. As life expec...
Tobacco mythbusters: tools for debunking common myths promoted by the tobacco industry
WHO consolidated guidelines on tuberculosis: Module 6: tuberculosis and comorbidities, 2nd ed
recommended
Addressing TB comorbidities and risk factors is central to the World Health Organization (WHO) End TB Strategy. These guidelines consolidate the latest WHO recommendations on TB and key comorbidities. The guidelines are a living document and will include dedicated sections for each key TB comorbidit...
In an era of constrained resources and tightening budgets, strategic prioritization in tuberculosis (TB) programming is more critical than ever. Countries must make informed decisions to allocate limited resources effectively - maximizing impact, preventing avoidable deaths, and sustaining progress ...
Global tuberculosis report 2025
recommended
The WHO Global tuberculosis report 2025 provides a comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
